Summary. The aim of this study was to elucidate the acute effects of vanadate on cell surface insulin binding and insulin sensitivity in rat adipocytes. The cells were preincubated at 37 ~ for 20 min followed by energy depletion with potassium cyanide, extensive washing and a25I-insulin binding. The presence of vanadate or insulin during the preincubation period dose-dependently enhanced ~25I-insulin binding to normal adipocytes (maximally 4-5-fold) through an increased number of binding sites without any change in receptor affinity. Submaximal concentrations of vanadate added together with insulin enhanced the cellular sensitivity to the effect of insulin to stimulate 3-O-methylglucose transport.
Vanadate is known to mimic several effects of insulin including the stimulation of glucose uptake and oxidation, glycogen synthesis as well as the anti-lipolytic effect [1] [2] [3] [4] [5] [6] . The mechanisms for these effects of vanadate are still not completely understood. Vanadate inhibits the Na+-K § ATPase but this effect has proven irrelevant for its insulinlike action [3] . In recent years much interest has been focused on the insulin receptor tyrosine kinase, which is activated by insulin and vanadate [4, 7, 8] and may be involved in signal transmission including that for the glucose transport system [9, 10] . However, there is also evidence that the insulin-like effects of vanadate can occur independently of tyrosine kinase activation [11, 12] . Thus, the role of this enzyme for vanadate action is still not clear. Green [13] suggested that vanadate entirely acts at a postreceptor level, since its effects were demonstrable in cells where the insulin receptors had been down-regulated or digested by trypsin.
The interaction between vanadate and the binding capacity of the insulin receptor at the cell surface has not been thoroughly investigated previously. Earlier studies have indicated that vanadate can decrease insulin binding in human monocytes and lymphocytes [14] and also in rat adipocytes following prolonged exposure [15] . However, the opposite has also been found [8] and a recent study reported increased receptor affinity following vanadate treatment of rat adipocytes [16] . We have recently found that insulin itself as well as vanadate is able to rapidly enhance the number of cell surface insulin binding sites [17] .
The aim of the present study was to further elucidate the interaction between vanadate and the binding of insulin to its receptor in both normal and insulin-resistant rat adipocytes. Following vanadate treatment, the cells were energy depleted to stop receptor cycling, thus allowing assessment of cell surface insulin binding [16] [17] [18] [19] [20] [21] [22] . In order to examine the effect of an altered binding on cellular insulin sensitivity, the dose-response relationship for the effect of insulin on glucose transport was also studied.
Materials and methods

Materials
Porcine monocomponent insulin and 125I-insulin (sp.act. 200-300 gCi/gg) were purchased from Novo (Copenhagen, Denmark). 14C-3-O-methylglucose (sp. act. 59 p~Ci/gmol) was from Amersham (Amersham, Buckinghamshire, UK) and 32P-ATP (sp. act. 3 Ci/gmol)) from DuPont (Geneva, Switzerland). Collagenase, bovine serum albumin (fraction V, BSA), wheat germ agglutinin (WGA), GluS~ 2~ N6-monobutyryl cyclic AMP (Nt-mbcAMP), Vanadate (retool/I) Fig. 1 . Effect of vanadate (or insulin) on 12sI-insulin binding in normal rat adipocytes. Adipocytes were preincubated at 37~ for 20 min with or without insulin and vanadate at the indicated concentrations. Following the addition of KCN and extensive washing, t25I-insulin binding was performed at 16 ~ as described in "Materials and methods". Data are means _+ SEM from eight separate experiments (insert) or from one representative experiment repeated four times. **p < 0.01, ***p < 0,001 compared to no addition 511 is sufficient to dissociate more than 90 % of the bound insulin. Aliquots of cells and medium were transferred to 16 ~ and 0.2 ng/ml l~I-insulin and 0--4.2 gg/ml unlabelled insulin added. After 2 h, when steady-state was reached, specific l~I-insulin binding was measured as cell-associated radioactivity remaining after subtracting non-specific binding (in the presence of 4.2 gg/ml unlabelled insulin).
Partial purification of insulin receptors and subsequent 125I-insulin binding
Aliquots of the cell suspension were treated with 0.5 % Triton X-100 in Hepes buffer (50 mmol/1, pH 7.4), containing 10 mmol/1 MgSO4 and the protease inhibitors leupeptin, aprotinin, pepstatin and phenylmethylsulphonyl fluoride. Following vortex-mixing and freezing at -80 ~ for 1 h, the cell suspension was thawed and homogenized. After centrifugation at 17,000 x g for 15 min at -4 ~ the triglyceride layer was carefully removed and the infranatant centrifuged at 100,000 x g for 60 rain. The supernatant was applied to a wheat germ agglutinin-agarose column and allowed to recirculate three times. After careful washing, the purified insulin receptors were eluted with 0. 
Cell preparation and incubation conditions
Male Sprague-Dawley rats, fed ad Iibitum, were stunned and decapitated at a weight of 160-200 g ("lean" animals, which were used in all studies unless otherwise specified) or 400M40 g ("obese"). The epididymal fat pads were immediately excised and minced. Fat ceils were isolated in medium 199 with 1 mg/ml collagenase and 40 mg/ml BSA. The cells were then filtered through a nylon mesh and washed four times with fresh medium. The preincubations were performed with the indicated agents, lipocrit (packed cell volume) 5-10 %, at 37 ~ for 20 min in the presence of 1 U/ml ADA. To stop receptor cycling the cells were then energy-depleted with 2 mmol/1 KCN for 5 min prior to the binding assays (unless otherwise specified).
a4C-3-O-methylglucose transport
This assay was performed as previously described [23] . Following preincubation with the indicated agents, aliquots of the cell suspension were pulsed with 14C-3-O-methylglueose (50 gmol/1, 1.0 gCi) without prior energy depletion. Glucose uptake was stopped after 5-10 s with ice-cold phloretin (0.3 mmol/1). Cell-associated radioactivity was measured and remaining extracellular 3-O-methylglucose subtracted.
125I-insulin binding to intact cells
To remove insulin, vanadate and other agents from the preincubation period that might directly interfere with binding, the cells were washed four times at 24~ in medium 199 with 10 mg/ml BSA and 2 mmol/1 KCN. Control experiments have shown that this procedure
Insulin receptor tyrosine kinase activity
Triplicate samples (40 gO of the eluate containing the purified insulin receptors were incubated for 15 rain at 20 ~ with 2 mmol/1 MnClz in the absence (when not otherwise indicated) or presence of 4.2 gg/ml insulin. 15 gmol/1 ATP was added for 15 min when GluS~ 2~ (2.5 mg/ml), 32P-ATP (-106 cpm) and unlabelled ATP (final concentration 15 gmol/1) were added to a total volume of 100 gl and the incubations continued for another 15 min. 75 p.1 aliquots were spotted on 3 MM papers (Whatman International, Maidstone, UK), washed with 10 % trichloroacetic acid containing 10 mmol/1 Na,P207 and then once with 95 % ethanol followed by 95 % acetone. Radioactivity was determined by scintillation counting and the background, obtained from samples lacking GluS~ a~ subtracted.
Statistical analysis
Statistical significance of differences was tested with Student's twotailed t-test for paired data. Results are expressed as means +_ SEM unless otherwise indicated.
Results
125I-insulin binding to normal cells
Preincubation with vanadate or insulin at maximally effective concentrations, followed by energy depletion and extensive washing, increased binding 4-5 fold compared to untreated cells ( Fig. 1, insert) . The effect was dose-dependent with an ECs0 (concentration producing 50 % of maximal effect) for vanadate -0.6 mmol/1 ( Fig. 1) . No additional response was exerted by concentrations higher than 4 retool/1 (not shown). Scatchard analysis confirmed that the enhanced insulin binding was due to an increase in To investigate if vanadate can directly interact with binding of insulin to its receptor, different concentrations of vanadate were added together with ~25I-insulin following KCN treatment. As seen in Figure 2 , vanadate inhibited 125I-insulin binding and this apparent competition was concentration-dependent, requiring higher vanadate levels ( > 1 mmol/1) than the stimulatory effect.
Experiments were also performed where the two opposite effects (Figs. 1 and 2, respectively) of vanadate, i. e., increase in binding capacity and apparent competition with insulin, were allowed to occur concomitantly. When cells were preincubated with 5 mmol/1 vanadate for 20 rain and 125I-insulin then added directly at 37~ without prior washing or energy depletion, the net effect was an approximate two-fold increase in insulin binding compared to untreated cells (not shown).
3-O-rnethylglucose transport in normal cells
Preincubation of adipocytes with vanadate increased the rate of 3-O-methylglucose transport in a concentrationdependent manner (Fig.3A) . Five mmol/1 vanadate (maximally effective concentration, not shown) and 1000 gU/ml insulin were equally effective and increased the transport rate about 7-8-fold (Fig. 3 A, insert) . No additive effect above this was seen by the addition of vanadate together with insulin (not shown).
The effect of vanadate on insulin sensitivity was examined by assessing the dose-response relationship for insulin-stimulated glucose transport (Fig. 3 B) . Submaximal concentrations of vanadate (0.5 and 2 mmol/1, respectively) enhanced insulin sensitivity and this was not explained merely by the insulin-mimetic effect of vanadate since that effect per se would produce a much smaller change (Fig. 3 B) . The presence of 0.5 mmol/1 vanadate (Fig. 3 B) reduced ECs0 for insulin (in control cells 23 + 7 ~xU/ml) by 45 + 3 % (n = 4, p < 0.001), whereas the corresponding effect of 2 mmol/1 vanadate was 60 + 2 % (n = 4, p < 0.001). Figure 4A shows ~25I-insulin binding to cells exposed to the non-metabolizable [24] cAMP-analogue N 6-mbcAMP (4 mmol/1). 125I-insulin binding was not changed by N6-mbcAMP alone. However, the effect of insulin pretreatment to increase binding (Figure 1, insert) was abolished in the presence of N6-mbcAMR whereas vanadate Insert: Absolute response to insulin (1000 gU/ml) in the absence or presence of vanadate in adipocytes from obese rats. Data are means + SEM of three to six separate experiments was still able to increase binding. The dose-response relationship for the vanadate-induced increase in insulin binding was similar to that in control cells (not shown). The cellular sensitivity to the effect of insulin to stimulate 3-O-methylglucose transport was markedly impaired by N6-mbcAMP (EC~0 48 + 11 vs 20 _+ 1 ~tU/ml in control cells, n = 4, p < 0.05, Fig. 4B ). However, when exposed to 0.5 mmol/1 vanadate, N6-mbcAMP-treated cells displayed a normal sensitivity to insulin (ECs0 22 _+ 4 gU/ml, n = 4, Fig.4B ). Two mmol/1 vanadate further increased the sensitivity to insulin to a "supranormal" level (ECs0 11 + 4 gU/ml, n = 4). The maximal response to insulin was not significantly changed by N6-mbcAMP and no additional response was seen in the presence of vanadate (not shown).
cAMP-treated cells
Amiloride-treated cells
The diuretic agent amiloride impairs insulin sensitivity in rat adipocytes, probably in part through a decreased effect of insulin to enhance receptor binding [22] . There was no difference in basal lZ~I-insulin binding between control cells and cells treated with i retool/1 amiloride (not shown). However, the effect of insulin to increase binding was severely blunted, whereas vanadate elicited an essentially normal response (not shown). As was seen with N6-mbcAMP-treated cells, vanadate (0.5 retool/l) prevented the effect of amiloride to decrease insulin sensitivity assessed from the dose-response curve for insulin-stimulated 3-O-methylglucose transport (not shown). 
Cells from aging, obese rats
Pretreatment of cells from old, obese rats with insulin did not increase insulin binding, whereas vanadate again produced a clear increase (Fig. 5 A) . However, the relative effect of vanadate was lower than in control cells (approximately two-fold above basal). As in the other insulin-resistant states, vanadate (0.5 retool/l) was capable of improving the impaired sensitivity to the effect of insulin on glucose transport and reduced ECs0 for insulin by 60 + 7 % (n = 3, p < 0.02, Fig. 5 B) . The maximal response to insulin was reduced in obese compared to control cells, (Fig. 5B  vs 3 A, inserted graphs), and it was not enhanced by vanadate.
Insulin receptor tyrosine kinase activity
Preincubation of the adipocytes with insulin induced a dose-dependent increase in the tyrosine kinase activity of partially purified insulin receptors (not shown). At the insulin concentrations used (0,10, 25,1000 gU/ml) vanadate (2 mmol/1) added to cells exerted an additive effect and increased the tyrosine kinase activity approximately two-fold compared to cells incubated without vanadate (n = 3-5,p < 0.05).
Discussion
This study clearly shows that the effect of vanadate to rapidly and markedly increase cell surface insulin binding capacity in normal rat adipocytes [17] is also demonstrable in insulin-resistant cells. This differs from the effect of insulin, which was seen only in normal, insulin- [16] reported that the effect of vanadate in augmenting insulin binding in rat adipocytes reaches maximum at a very low vanadate concentration (0.2 mmol/1). The reasons that this was seen at higher concentrations of vanadate @4 retool/l) in the present work may be: (1) the removal of vanadate prior to the binding assays thus dissociating the inhibitory component of vanadate action on insulin binding, (2) the degradation of adenosine by ADA, which per se impairs the cellular sensitivity to both insulin [25] and vanadate (not shown) and (3) a shorter time of vanadate exposure (20 vs 120 min).
The mechanisms for this novel effect of insulin and vanadate in enhancing the number of cell surface binding sites are still unclear as discussed extensively elsewhere [17] . However, recent data with affinity labelling of ~25I-insulin to intact fat cells show that the increased binding is recovered in isolated plasma membranes and that it occurs at the ~z-subunit of the insulin receptor as shown with SDS-PAGE combined with autoradiography (to be pubfished).
It may be expected that the increase in insulin binding exerted by vanadate leads to an enhanced cellular sensitivity to insulin. This was studied by assessing the concentration-response relationship for the ability of insulin to stimulate 3-O-methylglucose transport. The presence of submaximal vanadate concentrations, with less than halfmaximal intrinsic stimulatory action, clearly shifted the concentration-response curve for insulin to the left, indicating a greater sensitivity to insulin. This effect was not explained by the mere insulin-mimetic effect of vanadate, since the increase in insulin sensitivity would then have been much smaller. Instead, the enhanced insulin sensitivity (-two-fold) corresponds to the increased insulin-binding capacity (~two-fold) following exposure to 0.5 mmol/1 vanadate. Furthermore, the enhanced insulin sensitivity demonstrated is underestimated rather than overestimated, since the additional response induced by vanadate was most pronounced at low insulin concentrations.
To investigate whether vanadate-treatment in vitro is also efficient in insulin-resistant cells, we studied three different conditions of impaired insulin sensitivity, namely cells treated with N6-mbcAMP [24] [25] [26] [27] , amiloride [22] and cells from aging, obese rats [28] . The effect of insulin in increasing the number of cell surface binding sites is abolished or severely blunted in all these conditions indicating an importance of this effect in the regulation of insulin sensitivity. In contrast to insulin, vanadate produced a marked increase in insulin binding in all the insulin-resistant states studied. Accordingly, submaximal vanadate concentrations improved the sensitivity to the effect of insulin in stimulating glucose transport in the insulin-resistant cells. Figure 6 shows an attempt to assess the relationship between EC~0 for insulin-stimulated 3-O-methylglucose transport and the calculated increase in binding at the ECs0 level of insulin. When data from cells of varying degrees of insulin sensitivity in the presence or absence of different vanadate concentrations are compared, there is an apparently negative, non-linear correlation between the increase in insulin binding and ECs0 for insulin, supporting the importance of alterations in binding for insulin sensitivity. This also gives a fitting quantitative relationship with a two-fold increase in binding leading to an approximately 50 % reduction in ECs0. In this context it is interesting that in vivo, long-term treatment of diabetic rats or mice with vanadate can normalize the blood glucose levels as well as insulin-mediated glucose disposal and glycogen synthase activity [29] [30] [31] [32] .
Additional support for the importance of the increase in insulin binding for the effect of vanadate to enhance insulin sensitivity was provided by its failure to augment the maximal response to insulin in insulin-resistant cells. Had there been such an effect of vanadate, this would argue instead for the importance of post-receptor mechanisms [33] . Our data are thus in congruence with those of Fantus et al. [16] but conflict with the results of Green [13] who proposed an important post-receptor action of vanadate. This was based on a preserved effect on glucose uptake even when the cell surface receptors had been down-regulated or degraded by trypsin. One possibility for reconciling these observations with ours may be that the insulin-like response exerted by vanadate occurs mainly through post-receptor mechanisms, whereas the ability of vanadate to increase the cellular sensitivity to insulin is associated with an interaction at the insulin receptor level.
The insulin receptor tyrosine kinase has been proposed to play an important role both for the insulin signalling process [7, 9] and for vanadate action [8, 10] . However, there are also results suggesting that insulin [34] as well as vanadate [11, 12] may act independently of this enzyme. The present data show an additive effect of vanadate on insulin-stimulated tyrosine kinase activity but the impact of this for the effect of vanadate on insulin sensitivity is unclear. It is conceivable that both the increase in insulin binding and the augmented tyrosine kinase activity contribute to an amplification of the insulin signal and, thus, increase the insulin sensitivity. It is also possible that following vanadate or insulin binding, the stimulation of the tyrosine kinase occurs first and induces the increase in binding capacity either as a "positive feed-back" mechanism changing the conformation of the initially occupied receptor or through a lateral transphosphorylation and activation of neighbouring receptors [35] . The opposite 515 order, i. e., a conformational change leading to tyrosine kinase activation, is less likely, since we have demonstrated in insulin-resistant states (obesity, N6-mbcAMP-treatment) a normal or only slightly impaired tyrosine kinase activity [17] despite an abolished ability of insulin to increase binding.
In conclusion, the present data show that short-term exposure to insulin or vanadate increases cell surface insulin binding capacity in normal rat adipocytes. In contrast to insulin, the effect of vanadate was also demonstrable in insulin-resistant cells. The increase in insulin binding following vanadate is associated with an enhanced cellular sensitivity to insulin both in normal and insulin-resistant cells.
